Compare CNF & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CNF | ONMD |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 29.9M |
| IPO Year | 2018 | 2021 |
| Metric | CNF | ONMD |
|---|---|---|
| Price | $2.03 | $5.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.5K | ★ 27.1K |
| Earning Date | 08-28-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,359,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 111.35 |
| 52 Week Low | $1.37 | $0.63 |
| 52 Week High | $6.49 | $115.00 |
| Indicator | CNF | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.04 | 42.87 |
| Support Level | $1.74 | $3.86 |
| Resistance Level | $2.19 | $39.25 |
| Average True Range (ATR) | 0.12 | 0.52 |
| MACD | 0.02 | 0.85 |
| Stochastic Oscillator | 76.74 | 76.08 |
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.